Abstract
Mounting evidence shows that elevated heart rate (>80–85 beats/min) measured under resting conditions is directly associated with risk of developing hypertension and atherosclerosis, and is a potent predictor of cardiovascular morbidity and mortality. Several epidemiological studies have shown that these relationships are independent of other risk factors for atherosclerosis, and are present in individuals free of disease as well as in patients with cardiovascular disease. Experimental and clinical studies suggest that the haemodynamic disturbances related to elevated heart rate have a direct impact on the arterial wall, promoting the development of atherosclerotic plaques. In addition, heart rate has been directly related to the development of cardiovascular events associated with plaque disruption, which is statistically more likely as heart rate increases. In light of this evidence, heart rate should be included among the major risk factors for coronary heart disease.
Similar content being viewed by others
References
Palatini P, Julius S. Heart rate and the cardiovascular risk. J Hypertens 1997; 15: 3–17
Palatini P, Benetos A, Grassi G, et al. Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting. J Hypertens 2006; 24: 603–10
Levy RL, White PD, Stroud WD, et al. Transient tachycardia: prognostic significance alone and in association with transient hypertension. JAMA 1945; 129: 585–8
Dyer AR, Persky V, Stamler J, et al. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol 1980; 112: 736–49
Kannel WB, Kannel C, Paffenbarger Jr RS, et al. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987; 113: 1489–94
Gillum RF, Makuc DM, Feldman JJ. Pulse rate, coronary heart disease, and death: the NHANES I epidemiologic follow-up study. Am Heart J 1991; 121: 172–7
Menotti A, Mulder I, Nissinen A, et al. Cardiovascular risk factors and 10-year all-cause mortality in elderly European male populations: the FINE study (Finland, Italy, Netherlands, Elderly). Eur Heart J 2001; 22: 573–9
Gillmann MW, Kannel WB, Belanger A, et al. Influence of heart rate on mortality among persons with hypertension: the Framingham study. Am Heart J 1993; 125: 1148–54
Benetos A, Rudnichi A, Thomas F, et al. Influence of heart rate on mortality in a French population: role of age, gender and blood pressure. Hypertension 1999; 33: 44–52
Palatini P, Thijs L, Staessen JA, et al. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Arch Intern Med 2002; 162: 2313–21
Perk G, Stessman J, Ginsberg G, et al. Sex differences in the effect of heart rate on mortality in the elderly. J Am Geriatr Soc 2003; 51: 1260–4
Filipovsky J, Ducimetiere P, Safar ME. Prognostic significance of exercise blood pressure and heart rate in middle-aged men. Hypertension 1992; 20: 333–9
Reunanen A, Karjalainen J, Ristola P, et al. Heart rate and mortality. J Intern Med 2000; 247: 231–9
Savonen KP, Lakka TA, Laukkanen JA, et al. Heart rate response during exercise test and cardiovascular mortality in middle-aged men. Eur Heart J 2006; 27: 582–8
Jouven X, Empana JP, Schwartz PJ, et al. Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med 2005; 352: 1951–8
Palatini P, Casiglia E, Julius S, et al. High heart rate: a risk factor for cardiovascular death in elderly men. Arch Intern Med 1999; 159: 585–92
Disegni E, Goldbourt U, Reicher-Reiss H, et al. The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. SPRINT Study Group (Secondary Prevention Reinfarction Israeli Nifedipine Trial). J Clin Epidemiol 1995; 48: 1197–205
Berton GS, Cordiano R, Palmieri R, et al. Heart rate during myocardial infarction: relationship with one-year global mortality in men and women. Can J Cardiol 2002; 18: 495–502
Palatini P. Heart rate as a cardiovascular risk factor: do women differ from men? Ann Med 2001; 33: 213–21
Palatini P, Winnicki M, Santonastaso M, et al. Reproducibility of heart rate measured in the clinic and with 24-hour intermittent recorders. Am J Hypertens 2000; 13: 92–8
Aronow WS, Ahn C, Mercando AD, et al. Association of average heart rate on 24-hour ambulatory electrocardiograms with incidence of new coronary events at 48-months follow-up in 1,311 patients (mean age 81 years) with heart disease and sinus rhythm. Am J Cardiol 1996; 78: 1175–6
Sega R, Facchetti R, Bombelli M, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005; 111: 1777–83
Hozawa A, Ohkubo T, Kikuya M, et al. Prognostic value of home heart rate for cardiovascular mortality in the general population: the Ohasama study. Am J Hypertens 2004; 17: 1005–10
Hjalmarson A, Gilpin EA, Kjekshus J, et al. Influence of heart rate on mortality after acute myocardial infarction. Am J Cardiol 1990; 65: 547–53
Copie X, Hnatkova K, Staunton A, et al. Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction: results of a two-year follow-up study. J Am Coll Cardiol 1996; 27: 270–6
Abildstrom SZ, Jensen BT, Agner E, et al. Heart rate versus heart rate variability in risk prediction after myocardial infarction. J Cardiovasc Electrophysiol 2003; 14: 168–73
Lee KL, Woodlief LH, Topol EJ, et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation 1995; 91: 1659–68
Marchioli R, Avanzini F, Barzi F, et al. Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations: GISSI-Prevenzione mortality risk chart. Eur Heart J 2001; 22: 2085–103
Diaz A, Bourassa MG, Guertin MC, et al. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 2005; 26: 967–74
Bassiouny HS, Zarins CK, Kadowaki MH, et al. Hemodynamic stress and experimental aortoiliac atherosclerosis. J Vasc Surg 1994; 19: 426–34
Beere PA, Glagov S, Zarins CK. Retarding effect of lowered heart rate on coronary atherosclerosis. Science 1984; 226: 180–2
Kaplan JR, Manuck SB, Adams MR, et al. Inhibition of coronary atherosclerosis by propranolol in behaviorally predisposed monkeys fed an atherogenic diet. Circulation 1987; 76: 1364–72
Albaladejo P, Carusi A, Apartian A, et al. Effect of chronic heart rate reduction with ivabradine on carotid and aortic structure and function in normotensive and hypertensive rats. J Vasc Res 2003; 40: 320–8
Perski A, Olsson G, Landou C, et al. Minimum heart rate and coronary athero-sclerosis: independent relations to global severity and rate of progression of angiographic lesions in men with myocardial infarction at a young age. Am Heart J 1992; 123: 609–16
Huikuri HV, Jokinen V, Syvanne M, et al. Heart rate variability and progression of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1999; 19: 1979–85
Palatini P. Exercise haemodynamics in the normotensive and the hypertensive subject. (Editorial review). Clin Sci 1994; 87: 275–87
Mangoni AA, Mircoli L, Giannattasio C, et al. Heart rate-dependence of arterial distensibility in vivo. J Hypertens 1996; 14: 897–901
Mangoni AA, Mircoli L, Giannattasio C, et al. Effect of sympathectomy on mechanical properties of common carotid and femoral arteries. Hypertension 1997; 30: 1085–8
Heidland UE, Strauer BE. Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation 2001; 104: 1477–82
Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2007; 28: 2375–414
Acknowledgements
The author received funding from the University of Padova, Padova, Italy, to assist in the preparation of this review. Editorial support for the preparation of the manuscript was provided by Wolters Kluwer Health Medical Communications. The author has no conflicts of interest that are directly relevant to the content of this review.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Palatini, P. Heart Rate as an Independent Risk Factor for Cardiovascular Disease. Drugs 67 (Suppl 2), 3–13 (2007). https://doi.org/10.2165/00003495-200767002-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-200767002-00002